< Back to all clusters
[BUSINESS] · United States · 2 sources

started · updated

Neogen Corporation earnings forecast raised by Zacks Research

Zacks Research has increased its FY2027 earnings estimates for Neogen Corporation, raising the forecast to $0.25 per share from a previous estimate of $0.21. The firm also projected FY2029 earnings at $0.32 per share.

Neogen has received various ratings from other brokerages recently. Piper Sandler upgraded the company from neutral to overweight, raising the price target to $14.00, while Wall Street Zen upgraded it from hold to buy. The company's most recent quarterly earnings report showed $0.09 earnings per share, exceeding the consensus estimate of $0.06.

Entities

BlossomHill Therapeutics Inc. · Neogen Corporation · Revolution Medicines Inc. · Zacks Research